Loading…
← CockpitCompetitor Analysis › BON.PA Bonduelle SCAOpen in the cockpit ↗

Bonduelle SCABON.PACompetitor analysis, valuation and peers

France · EUR·Consumer Staples›Food: Specialty/Candy
Momentum strong 64
Mkt cap
$299M
US dollars, full cap
Free float
48%
of shares outstanding
$/day
$123,025
20-day average traded
Fwd P/E
8.2×
forward earnings
ROIC−WACC
-0.6 pp
WACC 5.5%
Hurdle
-3 pp
Req g minus delivered
Next earnings
100 days
26 Feb 2027
Close · EUR€8.48
1D-2.5%
1W-4.7%
1M-1.9%
3M-2.6%
6M+4.6%
YTD-19.2%
1Y-9.4%
ATR %3.7%
52w lowhigh25.4% off high

What Bonduelle SCA does

Employees: 7,445

Bonduelle SCA at a glance

Size Bonduelle SCA (BON.PA) is a France Consumer Staples company (Food: Specialty/Candy) with a market value of $299M, the 205th largest of 206 France companies the cockpit tracks. Shares closed at €8.48 on 18 Nov 2026.

Performance Over six months the shares gained 4.6%, against -7.9% for the median peer and -2.1% for the France market (cap-weighted) — 6th highest of 21 in its peer set.

Growth Revenue fell 0.8% over the last twelve months (peer median +5.1%); the operating margin is 3.6% (peer median 5.9%).

Valuation It trades at 8.2× forward earnings against a peer median of 20.3× (cheapest of 13).

Price implies For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is 0%, so the hurdle is -3 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 0.6 points below its cost of capital (5.5% WACC).

Next results Next results expected around 26 Feb 2027 (exchange calendar; dates can move).

Relative performance

9010011021 May 202621 Aug 202618 Nov 2026BON.PA 104Peer median 93
Six months, rebased to 100: Bonduelle SCA against the median of its 20 peers (local-currency closes).

Bonduelle SCA financials

Reported figures in EUR; fiscal year ends 2026-06-30. TTM = trailing twelve months.
TTMFY2026FY2025FY2024FY2023
Revenue€2.19B€2.19B€2.20B€2.22B€2.41B
Revenue growth—-1%-1%-8%—
Gross profit€84.4M€84.4M€80.2M€97.6M€80.6M
EBITDA€161M€148M€158M€148M€130M
Net income€16.2M€16.2M-€11.5M-€120M€14.5M
Free cash flow€29.6M€29.6M-€14.8M-€94.0M-€74.6M
Capital expenditure€69.3M€69.3M€82.3M€84.2M€77.5M
Total debtn/a€609M€582M€578M€449M

Quarterly statements and history in the cockpit →

Bonduelle SCA competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%-10%0%2908P342918TASTYBITE22260026610411ADVENZYMESGOPAL220712264027233012200027726037552211000972Q01300673603886BON.PA6-month return →1-month return →
Up and to the right = strong over both horizons. Bonduelle SCA is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%20×40×2908P342918ADVENZYMESGOPAL22071226402723301220603755300673603886BON.PARevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Bonduelle SCA is the large dot.

Capital: growth delivered against growth the price implies

0%+25%+50%+75%0%50%P342918TASTYBITE002661ADVENZYMES1226402723603755000972Q01300673BON.PAGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Bonduelle SCA is the large dot.

Bonduelle SCA competitors and peer comparison

How Bonduelle SCA compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Bonduelle SCA against its 20 peers (data as of 18 Nov 2026)
MeasureBON.PAPeer medianRank in peer set
1-month return-1.9%-3.4%9th highest of 21
6-month return+4.6%-7.9%6th highest of 21
Distance from 52-week high-25.4%-28.5%10th highest of 21
Revenue growth (TTM)-0.8%+5.1%4th lowest of 21
Operating margin3.6%5.9%7th lowest of 21
Forward P/E8.2×20.3×cheapest of 13
Growth the price implies (Req g, 7 yrs)-2.9%6.0%6th least demanding of 14
Growth delivered (Del g)+0.2%+4.2%3rd lowest of 14
Hurdle (Req g minus delivered)-3.2 pp-2.9 pp7th least demanding of 14
ROIC minus cost of capital-0.6 pp-1.0 pp10th highest of 21
EV / EBITDA5.3×8.6×5th cheapest of 14
Net debt / EBITDA3.6×0.3×2nd most indebted of 14

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Bonduelle SCA BON.PAFrance$299M+5%-1%4%8.2×-2.9%+0.2%
Fujicco 2908.TJapan$300M+7%-2%3%28.9×n/an/a
Delfi P34.SISingapore$301M-37%-2%7%9.8×-14.4%+4.2%
WARABEYA NICHIYO 2918.TJapan$295M0%+3%3%9.0×-1.5%+3.8%
Tasty Bite Eatables TASTYBITE.NSIndia$304M+50%+11%5%n/a52.0%+7.3%
KOIKE-YA 2226.TJapan$316M+1%+3%7%n/an/an/a
Chen Ke Ming Food Manufacturing 002661.SZChina$325M-22%+1%-4%n/a20.1%+1.9%
Lam Soon (Hong Kong) 0411.HKHong Kong$335M+12%+5%6%n/an/an/a
Advanced Enzyme Technologies ADVENZYMES.NSIndia$336M-27%+10%25%17.7×19.2%+8.3%
Gopal Snacks GOPAL.NSIndia$351M-10%+20%5%44.4×n/an/a
Meito 2207.TJapan$364M+18%+3%3%12.9×n/an/a
YEST 122640.KSSouth Korea$376M-12%+42%12%24.0×26.5%+5.7%
Gourmet Master 2723.TWTaiwan$380M+11%-10%8%12.0×-8.5%-1.7%
Kunshan Asia Aroma 301220.SZChina$380M-45%+13%6%22.9×9.6%+12.4%
Tianshui Zhongxing Bio-Technology 002772.SZChina$383M-52%+12%14%n/an/an/a
Qingdao Richen Food 603755.SSChina$383M-6%+11%17%31.2×19.2%+12.3%
Fujiya 2211.TJapan$391M+2%+6%1%n/an/an/a
Chalkis Health Industry 000972.SZChina$393M-10%+17%-52%n/a-6.9%+89.3%
QAF Q01.SISingapore$399M-10%0%6%n/a-11.0%+2.4%
Petpal Pet Nutrition Technology 300673.SZChina$403M-31%+2%6%41.4×6.0%+1.6%
Ganso 603886.SSChina$412M-1%+5%6%10.1×-14.0%-1.9%

Questions

Which companies are Bonduelle SCA's closest peers?
The cockpit's peer set: Fujicco (2908.T), Delfi (P34.SI), WARABEYA NICHIYO (2918.T), Tasty Bite Eatables (TASTYBITE.NS), KOIKE-YA (2226.T), Chen Ke Ming Food Manufacturing (002661.SZ), Lam Soon (Hong Kong) (0411.HK), Advanced Enzyme Technologies (ADVENZYMES.NS).
Is Bonduelle SCA expensive compared with its peers?
On forward p/e it trades at 8.2× against a peer median of 20.3×, cheapest of 13 in its peer set. For today's price to make sense, revenue must grow about -3% a year for seven years (Req g). Recent delivered growth is 0%, so the hurdle is -3 pp: the price already allows for a slowdown.
How has Bonduelle SCA stock performed?
Over six months to 18 Nov 2026 the shares returned +4.6% against -7.9% for the median peer; over one year -9.4%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.